Comparison of Self-Expanding Bioprostheses for Transcatheter Aortic Valve Replacement in Patients with Symptomatic Severe Aortic Stenosis: The SCOPE 2 Randomized Clinical Trial.

Corrado Tamburino,Sabine Bleiziffer,Holger Thiele,Smita Scholtz,David Hildick-Smith,Michael Cunnington,Alexander Wolf,Marco Barbanti,Didier Tchetche,Philippe Garot,Paolo Pagnotta,Martine Gilard,Francesco Bedogni,Eric Van Belle,Mariuca Vasa-Nicotera,Alaide Chieffo,Oliver Deutsch,Jörg Kempfert,Lars Søndergaard,Christian Butter,Ramiro Trillo-Nouche,Shahram Lotfi,Helge Möllmann,Michael D. Joner,Mohamed Abdel-Wahab,Kris Bogaerts,Christian Hengstenberg,Davide Capodanno

Comparison of Self-Expanding Bioprostheses for Transcatheter Aortic Valve Replacement in Patients with Symptomatic Severe Aortic Stenosis: The SCOPE 2 Randomized Clinical Trial.

2020

Background: There are few randomized trials comparing bioprostheses for transcatheter aortic valve replacement (TAVR), and no trials compared TAVR bioprostheses with supra-annular design. The SCOPE...

Keywords:

Medicine
Valve replacement
Randomized controlled trial
Surgery
transcatheter aortic
Stenosis
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations